Tracking changes in image‐defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Tao Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Neuroblastoma, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The capacity of presurgical image‐defined risk factors (IDRFs) to predict secondary surgical outcomes in patients with neuroblastoma is controversial.
Methods
The International Neuroblastoma Surgical Report Form (INSRF) was employed to retrospectively collect the clinical data of 53 patients diagnosed with neuroblastoma at our hospital from April 2014 to April 2020. IDRFs were identified at the time of diagnosis and reassessed during the course of neoadjuvant chemotherapy. Various statistical tests were used to evaluate the correlation between IDRFs and secondary surgical outcomes.
Results
A total of 195 IDRFs were identified. Notably, by two courses of neoadjuvant chemotherapy, the number of “two body compartments,” “intraspinal tumor extension,” and “trachea‐compressing” IDRFs decreased significantly ( p = .001). The primary tumor volumes and the number of IDRFs decreased significantly by four courses of neoadjuvant chemotherapy, especially in “intraspinal tumor extension” IDRFs ( p = .034). The median number of IDRF per patient was four (interquartile range [IQR]: 1–5) at diagnosis, which diminished to one (IQR: 1–3) subsequent to neoadjuvant chemotherapy. The presence of preoperative IDRFs was not associated with surgical complications ( p = .286) or the extent of surgery ( p = .188). However, the number of preoperative IDRFs linked to the extent of surgery ( p = .002), not to operative complications ( p = .669). Specifically, presurgery “renal vessel contact” IDRFs were predictive of surgical complications, while presurgery “infiltration of vital structures” IDRFs were associated with the extent of surgery.
Conclusion
The number of IDRFs decreased significantly by four courses of neoadjuvant chemotherapy. The number and type of presurgery IDRFs may predict secondary surgical outcomes, surpassing the mere consideration of their presence or absence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Hematology/Oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Radiology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Tao Liu
Zitieren
APA
Liu, T., Sheng, Q., Xu, W., Lu, L., Zhu, L., Xiong, J., Jiang, S., Yang, X., Liu, J., & Lv, Z. (2024). Tracking changes in image‐defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31161
Vancouver
Liu T, Sheng Q, Xu W, Lu L, Zhu L, Xiong J, et al. Tracking changes in image‐defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31161
BibTeX
@article{Liu2024,
author = {Liu, Tao and Sheng, Qingfeng and Xu, Weijue and Lu, Li and Zhu, Linlin and Xiong, Jing and Jiang, Shayi and Yang, Xiujun and Liu, Jiangbin and Lv, Zhibao},
title = {Tracking changes in image‐defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31161}
}
EUVIMED